Larimar Therapeutics

LRMR

Börsenwert 287 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	27,2 Mio. $	–	–	–
2	2 Deerfield Management New York	20,4 Mio. $	+14,6 Mio. $	+184.329	+262 %
3	3 Franklin Resources San Mateo, California	12,7 Mio. $	-495.691 $	-6.279	-4 %
4	4 Foresite Capital Management II Larkspur, California	9,5 Mio. $	-435.062 $	-5.511	-4 %
5	5 Foresite Capital Management III Larkspur, California	7,02 Mio. $	-321.461 $	-4.072	-4 %
6	6 Farallon Capital Management San Francisco, California	5,6 Mio. $	+1,18 Mio. $	+15.000	+27 %
7	7 BlackRock Fund Advisors San Francisco, California	5,25 Mio. $	+206.755 $	+2.619	+4 %
8	8 Vanguard Group Malvern, Pennsylvania	4,55 Mio. $	+171.704 $	+2.175	+4 %
9	9 VHCP Management New York	4,02 Mio. $	+398.906 $	+5.053	+11 %
10	10 BlackRock Institutional Trust San Francisco, California	2,72 Mio. $	-16.736 $	-212	-0,6 %
11	11 JP Morgan Chase New York	2,61 Mio. $	-184.335 $	-2.335	-7 %
12	12 Granahan Investment Management Waltham, Massachusetts	2,42 Mio. $	+487.797 $	+6.179	+26 %
13	13 State Street Boston, Massachusetts	2,27 Mio. $	-8,39 Mio. $	-106.329	-79 %
14	14 D.E. Shaw & Co New York	2,24 Mio. $	+2,21 Mio. $	+27.956	Neu
15	15 Deutsche Bank Frankfurt Am Main Ge, Germany	1,34 Mio. $	+38.051 $	+482	+3 %
16	16 Northern Trust Chicago, Illinois	1,25 Mio. $	-43.577 $	-552	-3 %
17	ARTA 17 A.R.T. Advisors New York	1,08 Mio. $	-52.656 $	-667	-5 %
18	18 Millennium Management New York	1,08 Mio. $	+383.196 $	+4.854	+57 %
19	19 Alyeska Investment Group Chicago, Illinois	1,03 Mio. $	-100.812 $	-1.277	-9 %
20	20 VHCP Management II New York	945.000 $	+930.753 $	+11.790	Neu
21	21 Geode Capital Management Boston, Massachusetts	856.000 $	+78.707 $	+997	+10 %
22	22 TIAA CREF Investment Management New York	784.000 $	+364.170 $	+4.613	+89 %
23	23 Harbourvest Partners Boston, Massachusetts	747.000 $	–	–	–
24	24 Candriam SCA Strassen, Luxembourg, Luxembourg	718.000 $	-81.549 $	-1.033	-10 %
25	25 Bank of New York Mellon New York	627.000 $	+123.548 $	+1.565	+25 %

Larimar Therapeutics LRMR Börsenwert 287 Mio. $

Larimar Therapeutics

LRMR

Börsenwert 287 Mio. $